Skip to main content
Equibles
ALGN logo

ALGN · Align Technology Inc

Track ALGN — free

Use ALGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ALGN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$158.94 -4.10 (-2.51%) At close · Aug 20
Market Cap
$11.29B
Shares
71.04M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$158.94 Open$162.52 Day$157.34–164.64 52W close$124.88–197.51 Avg vol 30d882K Short int4.2M · 5.9% float · 4.0d Short vol66% Last earningsJul 29, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −6%
      below
      Price vs 50-day avg −9%
      below
      RSI (14) 37
      neutral
      MACD trend Negative
      52-week position 47%
      mid-range
      Momentum
      relative strength
      Very Weak
      1-month return −6%
      trailing
      6-month return −16%
      trailing
      YTD return +2%
      this year
      Relative strength −28%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $175 › 200d $169 — 50d above 200d
      Institutional flow Distributing
      -4% holders QoQ · +72 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      5.92% of float · ▼ -12.9% MoM · 4.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      673 holders — near 3-yr low, contrarian setup
      Squeeze score 53
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +24%
      Y/Y
      Gross margin 700%
      contracting
      EPS growth +1%
      Y/Y
      Free cash flow $490.8M
      Valuation P/E 27.7
      below peers
      Buyback $733.3M
      remaining
      Balance sheet $1.1B
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 40%
      annualized · 1-yr
      Max drawdown −21%
      past year
      ATR 4.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 2 of last 3
      Latest guidance · from the 8-K filed Jul 29, 2026
      Q3'26
      GAAP Gross Margin Initiated 67.5% – 68.5%
      Non-GAAP Gross Margin Initiated 71%
      GAAP Operating Margin Initiated 13.5% – 15%
      Fiscal 2026
      Clear Aligner volume growth Initiated 6%
      GAAP Gross Margin Initiated 70.2% – 70.5%
      Capital expenditures Initiated $125M – $150M
      Share repurchases Initiated $400M – $500M
      Non-GAAP Operating Margin Initiated 23.7%
      GAAP Operating Margin Initiated 15.1% – 15.6%
      Non-GAAP gross margin Initiated 71.7%
      Q3 2026
      Non-GAAP operating margin Initiated 24%
      Prior guidance period ended · from the 8-K filed Feb 4, 2026
      Operating margin · Q1'26 12.4% – 12.8%
      Non-GAAP operating margin · Q1'26 19.5%
      Guided vs delivered · last 3 settled
      Worldwide revenues Q2 '24
      guided $1.03B – $1.05B
      $1.03B Miss −1.1%
      Worldwide revenue Q4 '23
      guided $920M – $940M
      $956.73M Beat +2.9%
      Worldwide revenue full year 2023
      guided $3.83B – $3.85B
      $3.86B Beat +0.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −6% Bearish
      Price vs 50-day avg
      −9% Bearish
      RSI (14)
      37 Neutral
      MACD trend
      Negative Bearish
      52-week position
      47% Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $175 › 200d $169 — 50d above 200d
      Institutional flow Distributing
      -4% holders QoQ · +72 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      5.92% of float · ▼ -12.9% MoM · 4.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      673 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      Range low $125 Now $159 · 47% Range high $198
      vs 200-day avg -6% vs 50-day avg -9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Clear Aligner Revenue Per Case Shipment $1,260 Q2 —
      doctor customers 302K second quarter 2026 —
      Invisalign Trained Doctor Utilization Rates 7.8 Q2 —
      Non-GAAP constant currency gross margin non-GAAP 73% Q2 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Non-GAAP gross margin 72.3%
      +0.8% Non-GAAP gross margin constant currency impact
      = Non-GAAP constant currency gross margin 73%
      Non-GAAP constant currency operating margin non-GAAP 24.4% Q2 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Non-GAAP operating margin 22.9%
      +1.5% Non-GAAP operating margin constant currency impact
      = Non-GAAP constant currency operating margin 24.4%
      Number of Invisalign Trained Doctors Cases Were Shipped To 89,175 Q2 —
      patients 23.5M the past 29 years —
      Clear Aligner shipments to GP Dentists 5.6% Q1'26 —
      Clear Aligner shipments to Orthodontists 7.4% Q1'26 —
      Invisalign adult patients 7.8% Q1'26 —
      Invisalign teen/kid patients 4.8% Q1'26 —
      active Invisalign trained doctors 295K 2025 —
      active iTero scanner units 121K 2025 —
      Clear Aligner volumes up year-over-year for adult patients 8% Q4'25 —
      Clear Aligner volumes up year-over-year in teens and kids 6.9% Q4'25 —
      Clear Aligner volumes up year-over-year in the GP dentist channel 5.3% Q4'25 —
      Clear Aligner volumes up year-over-year in the Orthodontic channel 8.9% Q4'25 —
      clear aligners manufactured worldwide 2.4B 2025 —
      doctors submitted Invisalign cases globally 87.7K Q4'25 —
      exocad CAD/CAM licenses 70K 2025 —
      Invisalign DSP Touch Up cases shipped 136K 2025 —
      Invisalign patients 22M 2025 —
      iTero Lumina share of full systems units 86% Q4'25 —
      teens and kids started treatment with Invisalign clear aligners 935.8K 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ALGN
      Align Technology Inc
      this stock
      		$11.29B +1.8% +23.9% 27.7 5.9%
      ISRG
      Intuitive Surgical Inc
      		 $140.51B -33.9% +20.5% 45.7 1.9%
      BDX
      Becton Dickinson & Co
      		 $49.24B — +8.2% — 3.7%
      MDLN
      Medline Inc.
      		 $44.58B -22.4% +11.5% — 2.6%
      ALC
      Alcon Inc
      		 $35.25B -7.5% +10.5% — 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      673
      % held
      103.6%
      Net QoQ
      +2.4M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      615
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      4.2M
      Days to cover
      4.0d
      Change
      -623.0K sh
      View
      Short Volume
      Short vol %
      66%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      200
      Value
      $33.6K
      As of
      Jul 24, 2026
      View
      Off-Exchange
      Off-exchange %
      45.4%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Sep 11, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $4.0B
      Net income (FY)
      $410.4M
      EPS diluted
      $5.65
      View
      Buybacks
      Authorized
      $1.0B
      Remaining
      $733.3M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 5, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $1.5M
      Shares
      8.0K
      Filed
      Feb 12, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 29, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ALGN -9.8% -5.5% -16.4% -6.0% +1.8%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY -7.8% -8.8% -27.6% -8.1% -10.0%

      Capital returns

      Buyback program · as of Jun 30, 2026
      Authorized
      $1.00B
      Spent (derived)
      $266.70M
      Remaining
      $733.30M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1097149 CUSIP 016255101 13F (30d) 601 filings 569 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)